Journal article

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.

  • Hou L Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
  • Heilbronner U Institute of Psychiatric Phenomics and Genomics, Ludwig-Maximilians-University Munich, Munich, Germany; Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August University Göttingen, Göttingen, Germany.
  • Degenhardt F Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Adli M Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany; Fliedner Klinik Berlin, Center for Psychiatry, Psychotherapy and Psychosomatic Medicine, Berlin, Germany.
  • Akiyama K Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Mibu, Japan.
  • Akula N Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
  • Ardau R Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
  • Arias B Department of Biologia Animal, Unitat d'Antropologia (Dp Biología Animal), Facultat de Biologia and Institut de Biomedicina (IBUB), Universitat de Barcelona, CIBERSAM, Barcelona, Catalonia, Spain.
  • Backlund L Department of Molecular Medicine and Surgery, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Banzato CEM Department of Psychiatry, University of Campinas (Unicamp), Campinas, Brazil.
  • Benabarre A Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Bengesser S Neurobiological Background and Anthropometrics in Bipolar Affective Disorder, Department of Psychiatry, Medical University of Graz, Graz, Austria.
  • Bhattacharjee AK Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Biernacka JM Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Birner A Neurobiological Background and Anthropometrics in Bipolar Affective Disorder, Department of Psychiatry, Medical University of Graz, Graz, Austria.
  • Brichant-Petitjean C INSERM UMR-S 1144-Université Paris Diderot Pôle de Psychiatrie, AP-HP, Groupe Hospitalier Lariboisière-F Widal, Paris, France.
  • Bui ET Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
  • Cervantes P The Neuromodulation Unit, McGill University Health Centre, Montreal, QC, Canada.
  • Chen GB The University of Queensland, Queensland Brain Institute, Brisbane, Queensland, QLD, Australia.
  • Chen HC Department of Psychiatry & Center of Sleep Disorders, National Taiwan University Hospital, Taipei, Taiwan.
  • Chillotti C Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
  • Cichon S Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Clark SR Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
  • Colom F Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Cousins DA Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK.
  • Cruceanu C Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
  • Czerski PM Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
  • Dantas CR Department of Psychiatry, University of Campinas (Unicamp), Campinas, Brazil.
  • Dayer A Department of Mental Health and Psychiatry, Mood Disorders Unit-Geneva University Hospitals, Geneva, Switzerland.
  • Étain B Inserm U955, Psychiatrie Translationnelle, Créteil, France.
  • Falkai P Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Forstner AJ Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Frisén L Department of Molecular Medicine and Surgery, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Clinical Neuroscience, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Child and Adolescent Psychiatry Research Center, Stockholm, Sweden.
  • Fullerton JM Mental Illness Research Theme, Neuroscience Research Australia, Sydney, NSW, Australia; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Gard S Pôle de Psychiatrie Générale Universitaire, Centre Hospitalier Charles Perrens, Bordeaux, France.
  • Garnham JS Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, NS, Canada.
  • Goes FS Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Grof P Mood Disorders Center of Ottawa, Ottawa, ON, Canada.
  • Gruber O Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August University Göttingen, Göttingen, Germany.
  • Hashimoto R Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan.
  • Hauser J Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
  • Herms S Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Hoffmann P Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Hofmann A Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Jamain S Inserm U955, Psychiatrie Translationnelle, Créteil, France.
  • Jiménez E Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Kahn JP Service de Psychiatrie et Psychologie Clinique, Centre Psychothérapique de Nancy-Laxou-Université de Lorraine, Nancy, France.
  • Kassem L Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
  • Kittel-Schneider S Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Kliwicki S Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
  • König B Department of Psychiatry and Psychotherapeutic Medicine, Landesklinikum Neunkirchen, Neunkirchen, Austria.
  • Kusumi I Department of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Lackner N Neurobiological Background and Anthropometrics in Bipolar Affective Disorder, Department of Psychiatry, Medical University of Graz, Graz, Austria.
  • Laje G Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
  • Landén M Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the Gothenburg University, Gothenburg, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Lavebratt C Department of Molecular Medicine and Surgery, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Leboyer M Assistance Publique-Hôpitaux de Paris, Hôpital Albert Chenevier-Henri Mondor, Pôle de Psychiatrie, Créteil, France.
  • Leckband SG Department of Molecular Medicine and Surgery, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Pharmacy, VA San Diego Healthcare System, San Diego, CA, USA.
  • Jaramillo CAL Department of Psychiatry, University of Antioquia, Medellín, Medellín, Colombia.
  • MacQueen G Department of Psychiatry, University of Calgary, Calgary, AB, Canada.
  • Manchia M Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy; Department of Pharmacology, Dalhousie University, Halifax, NS, Canada.
  • Martinsson L Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden.
  • Mattheisen M Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • McCarthy MJ Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA, USA.
  • McElroy SL Department of Psychiatry, Lindner Center of Hope, University of Cincinnati, Mason, OH, USA.
  • Mitjans M Department of Biologia Animal, Unitat d'Antropologia (Dp Biología Animal), Facultat de Biologia and Institut de Biomedicina (IBUB), Universitat de Barcelona, CIBERSAM, Barcelona, Catalonia, Spain.
  • Mondimore FM Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Monteleone P Neurosciences Section, Department of Medicine and Surgery, University of Salerno, Salerno, Italy; Department of Psychiatry, University of Naples SUN, Naples, Italy.
  • Nievergelt CM Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Nöthen MM Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Ösby U Department of Neurobiology, Care sciences, and Society, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Ozaki N Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Perlis RH Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Pfennig A Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
  • Reich-Erkelenz D Institute of Psychiatric Phenomics and Genomics, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Rouleau GA Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
  • Schofield PR Mental Illness Research Theme, Neuroscience Research Australia, Sydney, NSW, Australia; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Schubert KO Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
  • Schweizer BW Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Seemüller F Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Severino G Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Shekhtman T Veterans Administration, San Diego Healthcare System, San Diego, CA, USA; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Shilling PD Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Shimoda K Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan.
  • Simhandl C Bipolar Center Wiener Neustadt, Wiener Neustadt, Austria.
  • Slaney CM Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, NS, Canada.
  • Smoller JW Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Squassina A Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Stamm T Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
  • Stopkova P National Institute of Mental Health, Klecany, Czech Republic.
  • Tighe SK Department of Psychiatry, University of Iowa, Iowa City, IA, USA; University of Iowa Carver College of Medicine and University of Iowa College of Public Health, VA Quality Scholars Program, Iowa City VA Hospital, Iowa City, IA, USA.
  • Tortorella A Department of Psychiatry, University of Naples SUN, Naples, Italy.
  • Turecki G Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
  • Volkert J Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Witt S Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Wright A School of Psychiatry, University of New South Wales, and Black Dog Institute, Sydney, NSW, Australia.
  • Young LT Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Zandi PP Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Potash JB Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  • DePaulo JR Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Bauer M Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Medical Faculty, Technische Universität Dresden, Dresden, Germany.
  • Reininghaus EZ Neurobiological Background and Anthropometrics in Bipolar Affective Disorder, Department of Psychiatry, Medical University of Graz, Graz, Austria.
  • Novák T National Institute of Mental Health, Klecany, Czech Republic.
  • Aubry JM Department of Mental Health and Psychiatry, Mood Disorders Unit-Geneva University Hospitals, Geneva, Switzerland.
  • Maj M Department of Psychiatry, University of Naples SUN, Naples, Italy.
  • Baune BT Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
  • Mitchell PB School of Psychiatry, University of New South Wales, and Black Dog Institute, Sydney, NSW, Australia.
  • Vieta E Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Frye MA Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Rybakowski JK Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
  • Kuo PH Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan.
  • Kato T Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Saitama, Japan.
  • Grigoroiu-Serbanescu M Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Psychiatric Hospital, Bucharest, Romania.
  • Reif A Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt, Germany.
  • Del Zompo M Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Bellivier F INSERM UMR-S 1144-Université Paris Diderot Pôle de Psychiatrie, AP-HP, Groupe Hospitalier Lariboisière-F Widal, Paris, France.
  • Schalling M Department of Molecular Medicine and Surgery, Karolinska Institutet and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Wray NR The University of Queensland, Queensland Brain Institute, Brisbane, Queensland, QLD, Australia.
  • Kelsoe JR Veterans Administration, San Diego Healthcare System, San Diego, CA, USA; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Alda M Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, NS, Canada; National Institute of Mental Health, Klecany, Czech Republic.
  • Rietschel M Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • McMahon FJ Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA. Electronic address: mcmahonf@mail.nih.gov.
  • Schulze TG Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA; Institute of Psychiatric Phenomics and Genomics, Ludwig-Maximilians-University Munich, Munich, Germany; Department of Psychiatry and Psychotherapy, University Medical Center (UMG), Georg-August University Göttingen, Göttingen, Germany; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: thomas.schulze@med.uni-muenchen.de.
Show more…
  • 2016-01-26
Published in:
  • Lancet (London, England). - 2016
English BACKGROUND
Lithium is a first-line treatment in bipolar disorder, but individual response is variable. Previous studies have suggested that lithium response is a heritable trait. However, no genetic markers of treatment response have been reproducibly identified.


METHODS
Here, we report the results of a genome-wide association study of lithium response in 2563 patients collected by 22 participating sites from the International Consortium on Lithium Genetics (ConLiGen). Data from common single nucleotide polymorphisms (SNPs) were tested for association with categorical and continuous ratings of lithium response. Lithium response was measured using a well established scale (Alda scale). Genotyped SNPs were used to generate data at more than 6 million sites, using standard genomic imputation methods. Traits were regressed against genotype dosage. Results were combined across two batches by meta-analysis.


FINDINGS
A single locus of four linked SNPs on chromosome 21 met genome-wide significance criteria for association with lithium response (rs79663003, p=1·37 × 10(-8); rs78015114, p=1·31 × 10(-8); rs74795342, p=3·31 × 10(-9); and rs75222709, p=3·50 × 10(-9)). In an independent, prospective study of 73 patients treated with lithium monotherapy for a period of up to 2 years, carriers of the response-associated alleles had a significantly lower rate of relapse than carriers of the alternate alleles (p=0·03268, hazard ratio 3·8, 95% CI 1·1-13·0).


INTERPRETATION
The response-associated region contains two genes for long, non-coding RNAs (lncRNAs), AL157359.3 and AL157359.4. LncRNAs are increasingly appreciated as important regulators of gene expression, particularly in the CNS. Confirmed biomarkers of lithium response would constitute an important step forward in the clinical management of bipolar disorder. Further studies are needed to establish the biological context and potential clinical utility of these findings.


FUNDING
Deutsche Forschungsgemeinschaft, National Institute of Mental Health Intramural Research Program.
Language
  • English
Open access status
green
Identifiers
Persistent URL
https://sonar.ch/global/documents/116662
Statistics

Document views: 65 File downloads:
  • Full-text: 0